<DOC>
	<DOCNO>NCT01188655</DOCNO>
	<brief_summary>This observational study documentation prescribe administration practice Enbrel® impact ankylose spondylitis patient outcome real life setting .</brief_summary>
	<brief_title>Observational Non-Interventional Study With Enbrel ( Etanercept ) Patients With Ankylosing Spondylitis</brief_title>
	<detailed_description>The study population describe use standard descriptive statistic demographic , clinical , medical , characteristic , well standard health-related quality life functional disability questionnaire .</detailed_description>
	<mesh_term>Spondylitis</mesh_term>
	<mesh_term>Spondylitis , Ankylosing</mesh_term>
	<mesh_term>Etanercept</mesh_term>
	<criteria>Proven diagnosis Ankylosing Spondylitisin accordance local guideline Patients treated outpatient Patients suffer hypersensitivity active substance Etanercept excipients Enbrel® . Treatment Enbrel® initiate patient active infection include chronic localise infection . Patients sepsis risk sepsis treat .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2011</verification_date>
	<keyword>Ankylosing Spondylitis</keyword>
</DOC>